Skip to main content
Caplight Logo









Avulux

Avulux

Private
Aventura, FloridaHealthcare & Life Scienceshttps://avulux.com/

Last Round

Accelerator

Mar 24, 2025

Company Overview

Avulux is a therapeutic device company that develops and markets precision-engineered migraine and light sensitivity lenses.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, D2C Brands, Clinical Trials

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

migraine glasseslight sensitivityphotophobiaprecision-tinted lensesFL-41 glassesoptical filtersblue light glassesmigraine reliefphotochromic lensespolarized eyewearmedical eyewearDTC eyewearoptical technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Avulux Comparables

Compare Avulux with similar companies based on industry and business-model similarity.

Avulux comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TheraSpecs
84%
Sleepaxa Private Limited
83%
MigraLens
81%

Avulux Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMar 24, 2025

Avulux Investors

Notable investors and investment history

Avulux investors
InvestorRounds
The Consortium for Technology & Innovation in PediatricsAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 6, 2025

    Grew 16% QoQ, from 19 to 22 employees.

  • Jan 12, 2025

    Grew 27% QoQ, from 15 to 19 employees.

Avulux Filings

Explore SEC and related filing metadata, where available.

Avulux filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Avulux's valuation, stock price, and market status.

Is Avulux a public or private company?

Avulux is a private company.

What is the current stock price of Avulux?

Avulux is a private company with no public stock price. No recent secondary market data is available.

How much is Avulux worth (valuation)?

Valuation information for Avulux is not publicly available.

Can I buy Avulux stock?

Avulux shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Avulux's last funding round?

Avulux's most recent funding round was Accelerator on March 24, 2025.

Who are the main investors in Avulux?

Key investors in Avulux include The Consortium for Technology & Innovation in Pediatrics.

Will Avulux IPO soon?

No public IPO plans have been announced for Avulux.

How can I track Avulux secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Avulux's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAventura, Florida
Employee Range15
Year Founded2018
Last FundingMar 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?